PARP Inhibitors May Have Clinical Utility in HER2-Positive BC

Options

http://www.sciencedaily.com/releases/2012/09/120917084946.htm

PARP Inhibitors May Have Clinical Utility in HER2-Positive Breast Cancers

Categories